Literature DB >> 25934476

Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity.

Paul S de Vries1, Johan Boender2, Michelle A H Sonneveld3, Fernando Rivadeneira4, M Arfan Ikram5, Hanspeter Rottensteiner6, Albert Hofman1, André G Uitterlinden4, Frank W G Leebeek2, Oscar H Franco1, Abbas Dehghan1, Moniek P M de Maat2.   

Abstract

A disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAMTS13) cleaves von Willebrand factor, reducing its prothrombotic activity. The genetic determinants of ADAMTS13 activity remain unclear. We performed a genome-wide association study of ADAMTS13 activity in the Rotterdam Study, a population-based cohort study. We used imputed genotypes of common variants in a discovery sample of 3443 individuals and replication sample of 2025 individuals. We examined rare exonic variant associations in ADAMTS13 in 1609 individuals using an exome array. rs41314453 in ADAMTS13 was associated with ADAMTS13 activity in both our discovery (β, -20.2%; P = 1.3 × 10(-33)) and replication sample (P = 3.3 × 10(-34)), and explained 3.6% to 6.5% of the variance. In the combined analysis of our discovery and replication samples, there were 2 further independent associations at the ADAMTS13 locus: rs3118667 (β, 3.0; P = 9.6 × 10(-21)) and rs139911703 (β, -11.6; P = 3.6 × 10(-8)). In addition, rs10456544 in SUPT3H was associated with a 4.2 increase in ADAMTS13 activity (P = 1.13.6 × 10(-8)). Finally, we found 3 independent associations with rare coding variants in ADAMTS13: rs148312697 (β, -32.2%; P = 3.7 × 10(-6)), rs142572218 (β, -46.0%; P = 3.9 × 10(-5)), and rs36222275 (β, -13.9%; P = 2.9 × 10(-3)). In conclusion, we identified rs41314453 as the main genetic determinant of ADAMTS13 activity, and we present preliminary findings for further associations at the ADAMTS13 and SUPT3H loci.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25934476     DOI: 10.1182/blood-2015-02-629865

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.

Authors:  A B Ozel; B McGee; D Siemieniak; P M Jacobi; S L Haberichter; L C Brody; J L Mills; A M Molloy; D Ginsburg; J Z Li; K C Desch
Journal:  J Thromb Haemost       Date:  2016-08-19       Impact factor: 5.824

3.  Systems genetics identifies a macrophage cholesterol network associated with physiological wound healing.

Authors:  Marta Bagnati; Aida Moreno-Moral; Jeong-Hun Ko; Jérôme Nicod; Nathan Harmston; Martha Imprialou; Laurence Game; Jesus Gil; Enrico Petretto; Jacques Behmoaras
Journal:  JCI Insight       Date:  2019-01-24

4.  Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels.

Authors:  Qianyi Ma; Paula M Jacobi; Brian T Emmer; Colin A Kretz; Ayse Bilge Ozel; Beth McGee; Chava Kimchi-Sarfaty; David Ginsburg; Jun Z Li; Karl C Desch
Journal:  Blood Adv       Date:  2017-06-19

5.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

6.  Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis.

Authors:  Maria Teresa Pagliari; Luca A Lotta; Hugoline G de Haan; Carla Valsecchi; Gloria Casoli; Silvia Pontiggia; Ida Martinelli; Serena M Passamonti; Frits R Rosendaal; Flora Peyvandi
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

7.  ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study.

Authors:  Paul S de Vries; Thijs T W van Herpt; Symen Ligthart; Albert Hofman; M Arfan Ikram; Mandy van Hoek; Eric J G Sijbrands; Oscar H Franco; Moniek P M de Maat; Frank W G Leebeek; Abbas Dehghan
Journal:  Diabetologia       Date:  2016-10-27       Impact factor: 10.122

8.  The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.

Authors:  Michael Newnham; Kieron South; Marta Bleda; William R Auger; Joan A Barberà; Harm Bogaard; Katherine Bunclark; John E Cannon; Marion Delcroix; Charaka Hadinnapola; Luke S Howard; David Jenkins; Eckhard Mayer; Choo Ng; Christopher J Rhodes; Nicholas Screaton; Karen Sheares; Michael A Simpson; Mark Southwood; Li Su; Dolores Taboada; Matthew Traylor; Richard C Trembath; Sofia S Villar; Martin R Wilkins; John Wharton; Stefan Gräf; Joanna Pepke-Zaba; Michael Laffan; David A Lane; Nicholas W Morrell; Mark Toshner
Journal:  Eur Respir J       Date:  2019-03-28       Impact factor: 16.671

9.  Comparison of HapMap and 1000 Genomes Reference Panels in a Large-Scale Genome-Wide Association Study.

Authors:  Paul S de Vries; Maria Sabater-Lleal; Daniel I Chasman; Stella Trompet; Tarunveer S Ahluwalia; Alexander Teumer; Marcus E Kleber; Ming-Huei Chen; Jie Jin Wang; John R Attia; Riccardo E Marioni; Maristella Steri; Lu-Chen Weng; Rene Pool; Vera Grossmann; Jennifer A Brody; Cristina Venturini; Toshiko Tanaka; Lynda M Rose; Christopher Oldmeadow; Johanna Mazur; Saonli Basu; Mattias Frånberg; Qiong Yang; Symen Ligthart; Jouke J Hottenga; Ann Rumley; Antonella Mulas; Anton J M de Craen; Anne Grotevendt; Kent D Taylor; Graciela E Delgado; Annette Kifley; Lorna M Lopez; Tina L Berentzen; Massimo Mangino; Stefania Bandinelli; Alanna C Morrison; Anders Hamsten; Geoffrey Tofler; Moniek P M de Maat; Harmen H M Draisma; Gordon D Lowe; Magdalena Zoledziewska; Naveed Sattar; Karl J Lackner; Uwe Völker; Barbara McKnight; Jie Huang; Elizabeth G Holliday; Mark A McEvoy; John M Starr; Pirro G Hysi; Dena G Hernandez; Weihua Guan; Fernando Rivadeneira; Wendy L McArdle; P Eline Slagboom; Tanja Zeller; Bruce M Psaty; André G Uitterlinden; Eco J C de Geus; David J Stott; Harald Binder; Albert Hofman; Oscar H Franco; Jerome I Rotter; Luigi Ferrucci; Tim D Spector; Ian J Deary; Winfried März; Andreas Greinacher; Philipp S Wild; Francesco Cucca; Dorret I Boomsma; Hugh Watkins; Weihong Tang; Paul M Ridker; Jan W Jukema; Rodney J Scott; Paul Mitchell; Torben Hansen; Christopher J O'Donnell; Nicholas L Smith; David P Strachan; Abbas Dehghan
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.752

10.  The role of haematological traits in risk of ischaemic stroke and its subtypes.

Authors:  Eric L Harshfield; Matthew C Sims; Matthew Traylor; Willem H Ouwehand; Hugh S Markus
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.